Maxim Group initiated coverage on 180 Life Sciences Corp. with a new price target
$ATNF
Biotechnology: Pharmaceutical Preparations
Health Care
Maxim Group initiated coverage of 180 Life Sciences Corp. with a rating of Buy and set a new price target of $11.00